| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,196 | 18,259 | 16,801 | 17,309 | | Cost of Revenue | 4,829 | 5,103 | 5,147 | 5,532 | | | Gross Profit | 12,367 | 13,156 | 11,654 | 11,777 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,798 | 8,615 | 8,444 | 8,248 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,614 | 1,673 | 1,378 | 1,779 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 955 | 2,868 | 1,832 | 1,750 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 955 | 2,868 | 1,832 | 1,750 | | Interest Expense | 711 | 687 | 780 | 861 | | Income Before Tax | 244 | 2,181 | 1,052 | 889 | | Income Tax Expense | (516) | 282 | (104) | (139) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 760 | 1,899 | 1,156 | 1,028 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 760 | 1,899 | 1,156 | 1,028 | | Preferred Stock And Other Adjustments | (321) | (323) | (242) |
-
| | | Net Income Applicable To Common Shares | $439 | $1,576 | $914 | $1,028 |
|
0.49% Nasdaq 0.00%
Income Statement
